Invention Grant
- Patent Title: Anti-CEA antibodies
- Patent Title (中): 抗CEA抗体
-
Application No.: US14136299Application Date: 2013-12-20
-
Publication No.: US09206260B2Publication Date: 2015-12-08
- Inventor: Thomas U. Hofer , Ralf Hosse , Ekkehard Moessner , Pablo Umana
- Applicant: Roche Glycart AG
- Applicant Address: CH Schileren
- Assignee: Roche Glycart AG
- Current Assignee: Roche Glycart AG
- Current Assignee Address: CH Schileren
- Priority: EP11156665 20110302
- Main IPC: C07K16/30
- IPC: C07K16/30 ; C07K16/42 ; A61K39/00
Abstract:
The present invention provides antigen binding molecules (ABMs) which bind membrane-bound CEA, including ABMs with improved therapeutic properties, and methods of using the same.
Public/Granted literature
- US20140212408A1 Anti-CEA Antibodies Public/Granted day:2014-07-31
Information query
